The Japan Times - US researchers seek to legitimize AI mental health care

EUR -
AED 4.246478
AFN 76.888523
ALL 93.48757
AMD 423.347546
AOA 1061.345207
ARS 1733.058686
AUD 1.635994
AWG 2.082513
AZN 1.970043
BAM 1.961414
BBD 2.328364
BDT 143.103908
BHD 0.435989
BIF 3453.99514
BMD 1.156149
BND 1.48134
BOB 13.739681
BRL 5.892665
BSD 1.156009
BTN 110.002458
BWP 15.603659
BYN 3.442252
BYR 22660.520413
BZD 2.324924
CAD 1.611493
CDF 2615.791646
CHF 0.933942
CLF 0.026753
CLP 1056.362238
CNY 7.801236
CNH 7.796982
COP 3648.921861
CRC 525.515435
CUC 1.156149
CUP 30.637949
CVE 110.647961
CZK 24.266354
DJF 205.471255
DKK 7.476127
DOP 67.346134
DZD 153.688915
EGP 57.556612
ERN 17.342235
ETB 186.583498
FJD 2.553413
FKP 0.859298
GBP 0.856793
GEL 3.023376
GGP 0.859298
GHS 13.596763
GIP 0.859298
GMD 84.981404
GNF 10145.207892
GTQ 8.820244
GYD 241.852202
HKD 9.070596
HNL 30.984681
HRK 7.533703
HTG 151.152612
HUF 363.337748
IDR 20582.920659
ILS 3.468274
IMP 0.859298
INR 110.065674
IQD 1514.334158
IRR 1590340.758301
ISK 142.611425
JEP 0.859298
JMD 183.585438
JOD 0.819755
JPY 182.105612
KES 147.605987
KGS 101.105674
KHR 4685.298214
KMF 492.519879
KRW 1629.419037
KWD 0.356776
KYD 0.963357
KZT 541.790653
LAK 26108.739178
LBP 103533.143415
LKR 387.749774
LRD 209.899292
LSL 18.780552
LTL 3.413808
LVL 0.699343
LYD 7.358934
MAD 10.774363
MDL 20.102535
MGA 4933.054837
MKD 61.708483
MMK 2427.395773
MNT 4157.558143
MOP 9.341598
MRU 46.473418
MUR 54.420371
MVR 17.874501
MWK 2004.537163
MXN 19.809677
MYR 4.729001
MZN 73.883747
NAD 18.780552
NGN 1577.519501
NIO 42.541205
NOK 10.981266
NPR 176.003933
NZD 1.961655
OMR 0.444533
PAB 1.155994
PEN 3.915024
PGK 5.108776
PHP 70.28003
PKR 320.93685
PLN 4.299776
PYG 6873.88175
QAR 4.225923
RON 5.25054
RSD 117.323733
RUB 95.127146
RWF 1699.865164
SAR 4.370505
SBD 9.328213
SCR 16.756231
SDG 694.271725
SEK 10.952356
SGD 1.478142
SLE 28.445505
SOS 660.690956
SRD 43.779321
STD 23929.950059
STN 24.570322
SVC 10.115257
SZL 18.776741
THB 38.118659
TJS 10.664222
TMT 4.052302
TND 3.39612
TRY 55.147195
TTD 7.835596
TWD 37.302111
TZS 3060.902211
UAH 51.776356
UGX 4306.455826
USD 1.156149
UYU 46.534595
UZS 13825.989758
VES 871.980583
VND 30296.306488
VUV 137.59374
WST 3.154455
XAF 657.839796
XAG 0.018249
XAU 0.000266
XCD 3.124551
XCG 2.083463
XDR 0.818777
XOF 656.693016
XPF 119.331742
YER 273.834311
ZAR 18.677755
ZMK 10406.732529
ZMW 21.819165
ZWL 372.279507
  • CMSC

    0.0240

    21.744

    +0.11%

  • BCC

    2.3400

    86.6

    +2.7%

  • RBGPF

    0.6500

    70.6

    +0.92%

  • RELX

    0.0485

    35.52

    +0.14%

  • BCE

    -0.0200

    22.75

    -0.09%

  • BTI

    0.6000

    59.33

    +1.01%

  • GSK

    0.7900

    52.96

    +1.49%

  • CMSD

    -0.1600

    21.82

    -0.73%

  • RIO

    1.4500

    101.1

    +1.43%

  • NGG

    0.4700

    80.88

    +0.58%

  • JRI

    0.1500

    12.81

    +1.17%

  • RYCEF

    0.0500

    21

    +0.24%

  • VOD

    0.1900

    16.19

    +1.17%

  • BP

    -0.6000

    41.63

    -1.44%

  • AZN

    1.4100

    161.42

    +0.87%

US researchers seek to legitimize AI mental health care
US researchers seek to legitimize AI mental health care / Photo: Scott Eisen - GETTY IMAGES NORTH AMERICA/AFP/File

US researchers seek to legitimize AI mental health care

Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.

Text size:

Their application, Therabot, addresses the critical shortage of mental health professionals.

According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.

"We need something different to meet this large need," Jacobson told AFP.

The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.

A new trial is planned to compare Therabot's results with conventional therapies.

The medical establishment appears receptive to such innovation.

Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."

Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.

Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.

Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.

The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.

They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.

- Care or cash? -

With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.

According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.

Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.

Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.

"There are still a lot of questions," King noted.

To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.

While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.

Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.

The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."

- Therapist always in -

Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."

Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.

"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.

AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.

"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.

One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.

"I feel like it's working for me," he said.

"I would recommend it to people who suffer from anxiety and are in distress."

K.Abe--JT